Beese Fulmer Investment Management, Inc.
Source: SEC Form 13F · as of Mar 2026Beese Fulmer Investment Management, Inc. holds 28 biotech & pharma companies tracked by BioSniper, totaling $98.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
28
Total value held
$98.5M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 135,684 | $33.2M |
| PMPhilip Morris International Inc | 118,104 | $19.7M |
| ABTABBOTT LABORATORIES | 109,698 | $11.3M |
| ABBVAbbVie Inc. | 35,215 | $7.7M |
| LLYELI LILLY & Co | 6,047 | $5.6M |
| MCKMcKesson Corporation | 5,308 | $4.6M |
| MRKMerck & Co., Inc. | 30,114 | $3.6M |
| PFEPFIZER INC | 93,787 | $2.6M |
| BMYBRISTOL MYERS SQUIBB CO | 40,897 | $2.5M |
| BIIBBIOGEN INC. | 4,803 | $881K |
| CAHCardinal Health Inc. | 3,995 | $844K |
| AMGNAMGEN INC | 2,203 | $775K |
| REGNREGENERON PHARMACEUTICALS, INC. | 882 | $681K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,804 | $488K |
| ZTSZoetis Inc. | 3,888 | $460K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 7,606 | $430K |
| NVSNovartis AG | 2,490 | $380K |
| CORCencora Inc. | 1,179 | $370K |
| MEDPMedpace Holdings Inc. | 759 | $364K |
| UTHRUNITED THERAPEUTICS Corp | 594 | $352K |
| NBIXNEUROCRINE BIOSCIENCES INC | 2,634 | $347K |
| IDXXIDEXX LABORATORIES INC /DE | 510 | $287K |
| APLSApellis Pharmaceuticals, Inc. | 6,748 | $271K |
| ACHCAcadia Healthcare Company Inc. | 10,741 | $251K |
| GMOptec International, Inc. | 3,025 | $225K |
| DVADaVita Inc. | 1,362 | $209K |
| TECHBIO-TECHNE Corp | 3,921 | $205K |
| GOSSGossamer Bio, Inc. | 11,135 | $4K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.